Table 2: Mean insulin dose (U/kg/day ± sem) of 23 subjects treated with continuous subcutaneous insulin infusion (CSII) compared to 23 subjects treated by conventional therapy (CV) at the onset (T1) and at the end (T2) of the study period.
| T1 | T2 | p (ANOVA) | |
| CSII | 0.64 ± 0.04 | 0.70 ± 0.04 | 0.155 |
| CV | 0.57 ± 0.06 | 0.79 ± 0.03 | < 0.001 |
| p (ANOVA) | 0.240 | 0.097 |